A new score for the evaluation of palpable breast masses in women under age 40

Background: The purpose of this study was to develop a rapid and accurate diagnostic test for palpable breast masses in women under age 40. Methods: Masses were evaluated utilitzing a modified triple test score (MTTS), which assigned scores of 1 point for benign, 2 points for suspicious, or 3 points...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of surgery 2002-10, Vol.184 (4), p.346-347
Hauptverfasser: Morris, Katherine T, Vetto, John T, Petty, J.K, Lum, Sharon S, Schmidt, Waldemar A, Toth-Fejel, SuEllen, Pommier, Rodney F
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 347
container_issue 4
container_start_page 346
container_title The American journal of surgery
container_volume 184
creator Morris, Katherine T
Vetto, John T
Petty, J.K
Lum, Sharon S
Schmidt, Waldemar A
Toth-Fejel, SuEllen
Pommier, Rodney F
description Background: The purpose of this study was to develop a rapid and accurate diagnostic test for palpable breast masses in women under age 40. Methods: Masses were evaluated utilitzing a modified triple test score (MTTS), which assigned scores of 1 point for benign, 2 points for suspicious, or 3 points for malignant findings from physical examination, ultrasonography, and fine needle aspiration. The MTTS was the sum of the three scores and was correlated with biopsy or follow-up. Results: Among 113 masses, 100 scored 3 points, 8 scored 4 points; all were benign. Three scored 5 points; 1 was malignant. Two scored ≥6 points: both were malignant. Conclusions: The MTTS has 100% diagnostic accuracy when other than 5 points. Masses scoring ≤4 points are benign. Masses scoring ≥6 points may proceed to definitive therapy. Masses scoring 5 points (3%) require biopsy. This approach avoids open biopsy in the majority of cases, while capturing all malignancies.
doi_str_mv 10.1016/S0002-9610(02)00947-9
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72183074</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002961002009479</els_id><sourcerecordid>2847452812</sourcerecordid><originalsourceid>FETCH-LOGICAL-c419t-60e4d9c8e989dc9a1f19b9e80610300badef1ef5bb581d84d35447c4993a7b5c3</originalsourceid><addsrcrecordid>eNqFkE1LHTEUhoO06O3Vn2AJFEu7GE0mmTsnKxHphyC6UNchk5xpIzPJbTKj9N8bvReFbro6HHjel5eHkEPOjjnjq5MbxlhdqRVnX1j9lTEl20rtkAWHVlUcQLwji1dkj3zI-b68nEuxS_Z4LUCAggW5OqMBH2m2MSHtY6LTb6T4YIbZTD4GGnu6NsPadAPSLqHJEx1NzpipD_QxjhjoHBwman4hlWyfvO_NkPFge5fk7vu32_Of1eX1j4vzs8vKSq6masVQOmUBFShnleE9V51CYGWrYKwzDnuOfdN1DXAH0olGytZKpYRpu8aKJfm86V2n-GfGPOnRZ4vDYALGOeu25iBYKwv46R_wPs4plG26BtnKpoYiY0maDWVTzDlhr9fJjyb91ZzpZ936Rbd-dqnLfdGtVcl93LbP3YjuLbX1W4CjLWCyNUOfTLA-v3FCAYBsCne64bBIe_CYdLYeg0XnE9pJu-j_M-UJf3WZ_g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2847452812</pqid></control><display><type>article</type><title>A new score for the evaluation of palpable breast masses in women under age 40</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>ProQuest Central UK/Ireland</source><creator>Morris, Katherine T ; Vetto, John T ; Petty, J.K ; Lum, Sharon S ; Schmidt, Waldemar A ; Toth-Fejel, SuEllen ; Pommier, Rodney F</creator><creatorcontrib>Morris, Katherine T ; Vetto, John T ; Petty, J.K ; Lum, Sharon S ; Schmidt, Waldemar A ; Toth-Fejel, SuEllen ; Pommier, Rodney F</creatorcontrib><description>Background: The purpose of this study was to develop a rapid and accurate diagnostic test for palpable breast masses in women under age 40. Methods: Masses were evaluated utilitzing a modified triple test score (MTTS), which assigned scores of 1 point for benign, 2 points for suspicious, or 3 points for malignant findings from physical examination, ultrasonography, and fine needle aspiration. The MTTS was the sum of the three scores and was correlated with biopsy or follow-up. Results: Among 113 masses, 100 scored 3 points, 8 scored 4 points; all were benign. Three scored 5 points; 1 was malignant. Two scored ≥6 points: both were malignant. Conclusions: The MTTS has 100% diagnostic accuracy when other than 5 points. Masses scoring ≤4 points are benign. Masses scoring ≥6 points may proceed to definitive therapy. Masses scoring 5 points (3%) require biopsy. This approach avoids open biopsy in the majority of cases, while capturing all malignancies.</description><identifier>ISSN: 0002-9610</identifier><identifier>EISSN: 1879-1883</identifier><identifier>DOI: 10.1016/S0002-9610(02)00947-9</identifier><identifier>PMID: 12383898</identifier><identifier>CODEN: AJSUAB</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adolescent ; Adult ; Age groups ; Biological and medical sciences ; Biopsy ; Biopsy, Needle ; Breast ; Breast cancer ; Breast Neoplasms - diagnosis ; Deformities ; Diagnostic systems ; Female ; Fine needle aspiration ; Gynecology. Andrology. Obstetrics ; Humans ; Malignancy ; Mammary gland diseases ; Mammography ; Medical sciences ; Palpation ; Predictive Value of Tests ; Tumors ; Ultrasonic imaging ; Ultrasonography ; Ultrasonography, Mammary</subject><ispartof>The American journal of surgery, 2002-10, Vol.184 (4), p.346-347</ispartof><rights>2002 Elsevier Science Inc.</rights><rights>2002 INIST-CNRS</rights><rights>2002. Elsevier Science Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c419t-60e4d9c8e989dc9a1f19b9e80610300badef1ef5bb581d84d35447c4993a7b5c3</citedby><cites>FETCH-LOGICAL-c419t-60e4d9c8e989dc9a1f19b9e80610300badef1ef5bb581d84d35447c4993a7b5c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2847452812?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>309,310,314,777,781,786,787,3537,23911,23912,25121,27905,27906,45976,64364,64366,64368,72218</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13988845$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12383898$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Morris, Katherine T</creatorcontrib><creatorcontrib>Vetto, John T</creatorcontrib><creatorcontrib>Petty, J.K</creatorcontrib><creatorcontrib>Lum, Sharon S</creatorcontrib><creatorcontrib>Schmidt, Waldemar A</creatorcontrib><creatorcontrib>Toth-Fejel, SuEllen</creatorcontrib><creatorcontrib>Pommier, Rodney F</creatorcontrib><title>A new score for the evaluation of palpable breast masses in women under age 40</title><title>The American journal of surgery</title><addtitle>Am J Surg</addtitle><description>Background: The purpose of this study was to develop a rapid and accurate diagnostic test for palpable breast masses in women under age 40. Methods: Masses were evaluated utilitzing a modified triple test score (MTTS), which assigned scores of 1 point for benign, 2 points for suspicious, or 3 points for malignant findings from physical examination, ultrasonography, and fine needle aspiration. The MTTS was the sum of the three scores and was correlated with biopsy or follow-up. Results: Among 113 masses, 100 scored 3 points, 8 scored 4 points; all were benign. Three scored 5 points; 1 was malignant. Two scored ≥6 points: both were malignant. Conclusions: The MTTS has 100% diagnostic accuracy when other than 5 points. Masses scoring ≤4 points are benign. Masses scoring ≥6 points may proceed to definitive therapy. Masses scoring 5 points (3%) require biopsy. This approach avoids open biopsy in the majority of cases, while capturing all malignancies.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age groups</subject><subject>Biological and medical sciences</subject><subject>Biopsy</subject><subject>Biopsy, Needle</subject><subject>Breast</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - diagnosis</subject><subject>Deformities</subject><subject>Diagnostic systems</subject><subject>Female</subject><subject>Fine needle aspiration</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Malignancy</subject><subject>Mammary gland diseases</subject><subject>Mammography</subject><subject>Medical sciences</subject><subject>Palpation</subject><subject>Predictive Value of Tests</subject><subject>Tumors</subject><subject>Ultrasonic imaging</subject><subject>Ultrasonography</subject><subject>Ultrasonography, Mammary</subject><issn>0002-9610</issn><issn>1879-1883</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkE1LHTEUhoO06O3Vn2AJFEu7GE0mmTsnKxHphyC6UNchk5xpIzPJbTKj9N8bvReFbro6HHjel5eHkEPOjjnjq5MbxlhdqRVnX1j9lTEl20rtkAWHVlUcQLwji1dkj3zI-b68nEuxS_Z4LUCAggW5OqMBH2m2MSHtY6LTb6T4YIbZTD4GGnu6NsPadAPSLqHJEx1NzpipD_QxjhjoHBwman4hlWyfvO_NkPFge5fk7vu32_Of1eX1j4vzs8vKSq6masVQOmUBFShnleE9V51CYGWrYKwzDnuOfdN1DXAH0olGytZKpYRpu8aKJfm86V2n-GfGPOnRZ4vDYALGOeu25iBYKwv46R_wPs4plG26BtnKpoYiY0maDWVTzDlhr9fJjyb91ZzpZ936Rbd-dqnLfdGtVcl93LbP3YjuLbX1W4CjLWCyNUOfTLA-v3FCAYBsCne64bBIe_CYdLYeg0XnE9pJu-j_M-UJf3WZ_g</recordid><startdate>20021001</startdate><enddate>20021001</enddate><creator>Morris, Katherine T</creator><creator>Vetto, John T</creator><creator>Petty, J.K</creator><creator>Lum, Sharon S</creator><creator>Schmidt, Waldemar A</creator><creator>Toth-Fejel, SuEllen</creator><creator>Pommier, Rodney F</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20021001</creationdate><title>A new score for the evaluation of palpable breast masses in women under age 40</title><author>Morris, Katherine T ; Vetto, John T ; Petty, J.K ; Lum, Sharon S ; Schmidt, Waldemar A ; Toth-Fejel, SuEllen ; Pommier, Rodney F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c419t-60e4d9c8e989dc9a1f19b9e80610300badef1ef5bb581d84d35447c4993a7b5c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age groups</topic><topic>Biological and medical sciences</topic><topic>Biopsy</topic><topic>Biopsy, Needle</topic><topic>Breast</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - diagnosis</topic><topic>Deformities</topic><topic>Diagnostic systems</topic><topic>Female</topic><topic>Fine needle aspiration</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Malignancy</topic><topic>Mammary gland diseases</topic><topic>Mammography</topic><topic>Medical sciences</topic><topic>Palpation</topic><topic>Predictive Value of Tests</topic><topic>Tumors</topic><topic>Ultrasonic imaging</topic><topic>Ultrasonography</topic><topic>Ultrasonography, Mammary</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Morris, Katherine T</creatorcontrib><creatorcontrib>Vetto, John T</creatorcontrib><creatorcontrib>Petty, J.K</creatorcontrib><creatorcontrib>Lum, Sharon S</creatorcontrib><creatorcontrib>Schmidt, Waldemar A</creatorcontrib><creatorcontrib>Toth-Fejel, SuEllen</creatorcontrib><creatorcontrib>Pommier, Rodney F</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Morris, Katherine T</au><au>Vetto, John T</au><au>Petty, J.K</au><au>Lum, Sharon S</au><au>Schmidt, Waldemar A</au><au>Toth-Fejel, SuEllen</au><au>Pommier, Rodney F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A new score for the evaluation of palpable breast masses in women under age 40</atitle><jtitle>The American journal of surgery</jtitle><addtitle>Am J Surg</addtitle><date>2002-10-01</date><risdate>2002</risdate><volume>184</volume><issue>4</issue><spage>346</spage><epage>347</epage><pages>346-347</pages><issn>0002-9610</issn><eissn>1879-1883</eissn><coden>AJSUAB</coden><abstract>Background: The purpose of this study was to develop a rapid and accurate diagnostic test for palpable breast masses in women under age 40. Methods: Masses were evaluated utilitzing a modified triple test score (MTTS), which assigned scores of 1 point for benign, 2 points for suspicious, or 3 points for malignant findings from physical examination, ultrasonography, and fine needle aspiration. The MTTS was the sum of the three scores and was correlated with biopsy or follow-up. Results: Among 113 masses, 100 scored 3 points, 8 scored 4 points; all were benign. Three scored 5 points; 1 was malignant. Two scored ≥6 points: both were malignant. Conclusions: The MTTS has 100% diagnostic accuracy when other than 5 points. Masses scoring ≤4 points are benign. Masses scoring ≥6 points may proceed to definitive therapy. Masses scoring 5 points (3%) require biopsy. This approach avoids open biopsy in the majority of cases, while capturing all malignancies.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>12383898</pmid><doi>10.1016/S0002-9610(02)00947-9</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-9610
ispartof The American journal of surgery, 2002-10, Vol.184 (4), p.346-347
issn 0002-9610
1879-1883
language eng
recordid cdi_proquest_miscellaneous_72183074
source MEDLINE; Elsevier ScienceDirect Journals; ProQuest Central UK/Ireland
subjects Adolescent
Adult
Age groups
Biological and medical sciences
Biopsy
Biopsy, Needle
Breast
Breast cancer
Breast Neoplasms - diagnosis
Deformities
Diagnostic systems
Female
Fine needle aspiration
Gynecology. Andrology. Obstetrics
Humans
Malignancy
Mammary gland diseases
Mammography
Medical sciences
Palpation
Predictive Value of Tests
Tumors
Ultrasonic imaging
Ultrasonography
Ultrasonography, Mammary
title A new score for the evaluation of palpable breast masses in women under age 40
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T18%3A26%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20new%20score%20for%20the%20evaluation%20of%20palpable%20breast%20masses%20in%20women%20under%20age%2040&rft.jtitle=The%20American%20journal%20of%20surgery&rft.au=Morris,%20Katherine%20T&rft.date=2002-10-01&rft.volume=184&rft.issue=4&rft.spage=346&rft.epage=347&rft.pages=346-347&rft.issn=0002-9610&rft.eissn=1879-1883&rft.coden=AJSUAB&rft_id=info:doi/10.1016/S0002-9610(02)00947-9&rft_dat=%3Cproquest_cross%3E2847452812%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2847452812&rft_id=info:pmid/12383898&rft_els_id=S0002961002009479&rfr_iscdi=true